Similar articles

• Antibody testing for cardiac antibody-mediated rejection: which panel correlates best with cardiovascular death?

  Revelo MP, Stehlik J, Miller D, Snow GL, Everitt MD, Budge D, Bader FM, Alharethi RA, Gilbert EM, Reid BB, Selzman CH, Hammond ME, Kfoury AG. Revelo MP, et al. J Heart Lung Transplant. 2011 Feb;30(2):144-50. doi: 10.1016/j.healun.2010.06.019. Epub 2010 Sep 19. J Heart Lung Transplant. 2011. PMID: 20855221
• Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads.

  Chen G, Sequeira F, Tyan DB. Chen G, et al. Hum Immunol. 2011 Oct;72(10):849-58. doi: 10.1016/j.humimm.2011.07.001. Epub 2011 Jul 18. Hum Immunol. 2011. PMID: 21791230
• Decay-accelerating factor expression may provide immunoprotection against antibody-mediated cardiac allograft rejection.

  González-Stawinski GV, Tan CD, Smedira NG, Starling RC, Rodríguez ER. González-Stawinski GV, et al. J Heart Lung Transplant. 2008 Apr;27(4):357-61. doi: 10.1016/j.healun.2008.01.008. J Heart Lung Transplant. 2008. PMID: 18374870
• [Monitoring of allograft rejection].

  Namba Y, Takahara S. Namba Y, et al. Nihon Rinsho. 2005 Apr;63 Suppl 4:706-10. Nihon Rinsho. 2005. PMID: 15861733 Review. Japanese. No abstract available.
• Diagnosis and treatment of antibody-mediated kidney allograft rejection.

  Böhmig G, Regele H. Böhmig G, et al. Transpl Int. 2003 Nov;16(11):773-87. doi: 10.1007/s00147-003-0658-3. Epub 2003 Oct 8. Transpl Int. 2003. PMID: 14534774 Review.